Open Access | Therapeutic Brief This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
Key finding: AOD 9604 reduced serum leptin by 56%, improved hypothalamic STAT3 phosphorylation, and restored leptin-induced POMC expression
doi:10.1007/s00380-004-0822-4
This gets asked about more than anything else, and the honest answer is that it does not need cycling the way a growth hormone secretagogue does
For eloralintide, GI symptoms and fatigue were the most common adverse events, mild to moderate, and clearly dose-dependent: they appeared more often in the higher-dose arms, occurred less often with slower escalation, and ran at rates similar to placebo in the 1 mg and 3 mg arms
AIT combines the actions of acupuncture with vitamin B/homeopathic biomedical pharmaceuticals that are FDA regulated